Genmab — Juli 2020
-
JvdW bliver rådgiver for hollandsk venturafond. https://medwatch.dk/Medicinal___Biotek/article12279929.ece
-
God morgen.
-
Daratumumab for disabling cold agglutinin disease refractory to B‐cell directed therapy https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25932
-
-
Helge Larsen
har delt et link.
Administrator
· 1 min · Delt med Medlemmer af PROINVESTORS PHARMA - OG BIOTEK SNAK
Fred være med lidt modvind. De danske sundhedsaktier strutter fundamentalt af sundhed. Det gør de også på den lange bane.https://finans.dk/privatokonomi/ECE12275932/guldrandede-danske-sundhedsaktier-moeder-modvind-paa-finansmarkedet/?utm_source=dlvr.it&utm_medium=twitter&ctxref=ext&fbclid=IwAR3d8Qht9JCFhri61P0f1Gu-Q-DHZv2PUEhAaSKEOLn1MGE6mz6UAo5-Pho -
@pensionisten - linket virker ikke
-
Er det ikke det samme link som jeg lagde i går aftes kl. 20.12. https://finans.dk/privatokonomi/ECE12275932/guldrandede-danske-sundhedsaktier-moeder-modvind-paa-finansmarkedet/?utm_source=dlvr.it&utm_medium=twitter&ctxref=ext&fbclid=IwAR3d8Qht9JCFhri61P0f1Gu-Q-DHZv2PUEhAaSKEOLn1MGE6mz6UAo5-Pho
-
Fred være med det.
-
Må dog konstatere at Novo, GEN, ZEAL, BAVA og AMBU falder i åbningen. Så mange kan der da ikke være som læser Jyllandspostens finansside.
-
Lancet - Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(20)30144-7/fulltext
-
Nogen estimater på Q2 salgstal torsdag? Jeg lægger ud gæt med USD 980M!
-
DnB Markets
Rune Majlund Dahl
Genmab (Hold, TP: DKK2400.00) - Limited Covid-19 impact
We expect slightly lower Darzalex sales in Q2 QOQ due to Covid-19, and estimate global sales of USD936m. We are at the mid-point of the USD3.9bn–4.2bn sales guidance for 2020e. -
-
another PET/CT Scan trial With the Radioactive Tracer 89Zr-DFO-Daratumumab https://clinicaltrials.gov/ct2/show/NCT04467281?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=07%2F13%2F2020&draw=2&rank=1
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind